Clinical Research, Powered by YOU™

Evaluating the safety and outcomes of patient's own cell-derived Secretome for skin and hair.

Our Research Standards

  • Publicly Registered

    All Acorn studies are registered on ClinicalTrials.gov, making their design and endpoints transparent from the start.

  • Run with Leading Clinical Partners

    Our research is conducted in established medical practices, in the same settings where patients receive care.

  • Rated by Patients and Providers

    Outcomes are evaluated by both participants and treating clinicians, combining patient-reported and clinical measures.

Acorn Clinical Research

Study Pipeline

ACN-101: Skin, Hair & Scar Recovery

Enrolling

View Study Details
Study type
Multi-site, prospective, observational study
Who is it for?
Adults planning a microneedling or a laser procedure
Clinical trial ID
NCT06477172

Goal: To collect real-world data on YOU™ Secretome, a topical product derived from the patient's own hair follicles, used after medical aesthetic procedures.

  • Procedures: Microneedling or laser on the face, scalp or scars
  • Measured: Recovery, downtime, skin and hair improvement, rated by patients and providers
  • Study sites: Partner clinics across the US and Canada

To join, contact Lisa Campbell at [email protected].

Injectable Secretome Treatment for Facial Rejuvenation

Enrolling

View Study Details
Study type
Randomized, double-blind, placebo-controlled trial
Who is it for?
Adults 30–75 who can attend visits in Newport Beach, CA
Clinical trial ID
NCT07227883

Goal: To evaluate the safety and efficacy of the participant’s own Secretome for facial rejuvenation.

  • Treatment: Injections to the under-eye area, and on each side of the face, including cheeks, nasolabial folds and marionette lines
  • Duration: 120 days; placebo participants may then cross over to active treatment
  • Study site: Dr. Steve Yoelin, Newport Beach, CA

For pre-screening, contact Lisa Campbell at [email protected].

Injectable Secretome for Androgenic Alopecia

Ongoing

View Study Details
Study type
Randomized, double-blind, placebo-controlled trial
Who is it for?
Adults 18–65 with pattern hair loss, on a stable minoxidil and finasteride/dutasteride routine for 6+ months, who can attend visits in West Hollywood, CA
Clinical trial ID
NCT07107841

Goal: Evaluate the safety and efficacy of the participant’s own Secretome for androgenetic alopecia.

  • Treatment: Scalp injections, 3 sessions over 12 months
  • Measured: Hair density, thickness and patient-reported outcomes
  • Study site: Ziering Medical, West Hollywood, CA

For pre-screening, contact Lisa Campbell at [email protected].

Participate

Become Part of the Research

Interested in joining a study, or in bringing Acorn research to your practice? Our clinical team can answer your questions.

Contact Us